Search research articles
Contact Us
Filters
Showing results (71-80 of 128) with videos related to
Page
of 13
Sort By:
Journal of Clinical Medicine
|
July 2, 2021
Rapid Isothermal Amplification for the Buccal Detection SARS-CoV-2 in the Context of Out-Patient COVID-19 Screening
Amar Bouam, Jean-Jacques Vincent, Elisabeth Le Glass, et al.
Frontiers in Immunology
|
June 14, 2019
DC Subsets Regulate Humoral Immune Responses by Supporting the Differentiation of Distinct Tfh Cells
Aurélie Bouteau, Jérôme Kervevan, Qingtai Su, et al.
Journal of Clinical Medicine
|
April 26, 2025
RETRACTED: Bouam et al. Rapid Isothermal Amplification for the Buccal Detection SARS-CoV-2 in the Context of Out-Patient COVID-19 Screening. <i>J. Clin. Med.</i> 2021, <i>10</i>, 2643
Amar Bouam, Jean-Jacques Vincent, Elisabeth Le Glass, et al.
International Orthopaedics
|
April 14, 2017
Staphylococcus lugdunensis: a neglected pathogen of infections involving fracture-fixation devices
Piseth Seng, Madou Traore, Jean-Philippe Lavigne, et al.
Plos One
|
July 27, 2010
Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy
Laurence Weiss, Christophe Piketty, Lambert Assoumou, et al.
Nature
|
March 16, 2017
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Benjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Nature
|
June 29, 2017
Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Benjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 28, 2011
Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy
Scott L Butler, Hernan Valdez, Michael Westby, et al.
European Journal of Immunology
|
December 19, 2015
Intradermal injection of an anti-Langerin-HIVGag fusion vaccine targets epidermal Langerhans cells in nonhuman primates and can be tracked in vivo
Nina Salabert, Biliana Todorova, Frédéric Martinon, et al.
The Journal of Clinical Investigation
|
August 28, 2018
TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs
Liang Cheng, Qi Wang, Guangming Li, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 128) with videos related to
Sort By:
Page
of 13
Journal of Clinical Medicine
|
July 2, 2021
Rapid Isothermal Amplification for the Buccal Detection SARS-CoV-2 in the Context of Out-Patient COVID-19 Screening
Amar Bouam, Jean-Jacques Vincent, Elisabeth Le Glass, et al.
Frontiers in Immunology
|
June 14, 2019
DC Subsets Regulate Humoral Immune Responses by Supporting the Differentiation of Distinct Tfh Cells
Aurélie Bouteau, Jérôme Kervevan, Qingtai Su, et al.
Journal of Clinical Medicine
|
April 26, 2025
RETRACTED: Bouam et al. Rapid Isothermal Amplification for the Buccal Detection SARS-CoV-2 in the Context of Out-Patient COVID-19 Screening. <i>J. Clin. Med.</i> 2021, <i>10</i>, 2643
Amar Bouam, Jean-Jacques Vincent, Elisabeth Le Glass, et al.
International Orthopaedics
|
April 14, 2017
Staphylococcus lugdunensis: a neglected pathogen of infections involving fracture-fixation devices
Piseth Seng, Madou Traore, Jean-Philippe Lavigne, et al.
Plos One
|
July 27, 2010
Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy
Laurence Weiss, Christophe Piketty, Lambert Assoumou, et al.
Nature
|
March 16, 2017
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Benjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Nature
|
June 29, 2017
Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses
Benjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 28, 2011
Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy
Scott L Butler, Hernan Valdez, Michael Westby, et al.
European Journal of Immunology
|
December 19, 2015
Intradermal injection of an anti-Langerin-HIVGag fusion vaccine targets epidermal Langerhans cells in nonhuman primates and can be tracked in vivo
Nina Salabert, Biliana Todorova, Frédéric Martinon, et al.
The Journal of Clinical Investigation
|
August 28, 2018
TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs
Liang Cheng, Qi Wang, Guangming Li, et al.
Page
of 13